TY - JOUR
T1 - Antimicrobial resistance. Its importance and efforts to control it
AU - Giono-Cerezo, Silvia
AU - Santos-Preciado, José I.
AU - Morfín-Otero, María Del Rayo
AU - Torres-López, Francisco J.
AU - Alcántar-Curiel, María Dolores
N1 - Publisher Copyright:
© 2020 Academia Nacional de Medicina de México, license.
PY - 2020
Y1 - 2020
N2 - The World Health Organization estimates that bacterial resistance will cause 10 million deaths by 2050. As part of the Global Action Plan on Antimicrobial Resistance, it proposed networks of specialized laboratories in order to preserve strains and optimize the use of antimicrobials. That is the case of the Latin American Surveillance Network of Antimicrobials Resistance. In a 2019 study, the main bacteria of the ESKAPE group (which are highly resistant to the most widely used antibiotics) that cause infections in Mexican Hospitals were identified to be multidrug-resistant (MDR) and extended-spectrum beta-lactamase (ESBL)-producing Klebsiella spp., ESBL-producing Enterobacter spp., Acinetobacter baumannii, MDR Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. With information on drug resistance, regimens are recommended to treat infection caused by Helicobacter pylori, a pathogen related to the development of cancer and whose prevalence in the adult population of Latin America is estimated to range between 60 and 70 %.
AB - The World Health Organization estimates that bacterial resistance will cause 10 million deaths by 2050. As part of the Global Action Plan on Antimicrobial Resistance, it proposed networks of specialized laboratories in order to preserve strains and optimize the use of antimicrobials. That is the case of the Latin American Surveillance Network of Antimicrobials Resistance. In a 2019 study, the main bacteria of the ESKAPE group (which are highly resistant to the most widely used antibiotics) that cause infections in Mexican Hospitals were identified to be multidrug-resistant (MDR) and extended-spectrum beta-lactamase (ESBL)-producing Klebsiella spp., ESBL-producing Enterobacter spp., Acinetobacter baumannii, MDR Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. With information on drug resistance, regimens are recommended to treat infection caused by Helicobacter pylori, a pathogen related to the development of cancer and whose prevalence in the adult population of Latin America is estimated to range between 60 and 70 %.
KW - Antimicrobial resistance
KW - ESKAPE group
KW - Helicobacter pylori
KW - National Strategy
UR - http://www.scopus.com/inward/record.url?scp=85085073280&partnerID=8YFLogxK
U2 - 10.24875/GMM.M20000358
DO - 10.24875/GMM.M20000358
M3 - Artículo
C2 - 32285851
AN - SCOPUS:85085073280
SN - 0016-3813
VL - 156
SP - 171
EP - 178
JO - Gaceta Medica de Mexico
JF - Gaceta Medica de Mexico
IS - 2
ER -